Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion type Assertion NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_head.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion description "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion evidence source_evidence_literature NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion SIO_000772 25129346 NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion wasDerivedFrom befree-2016 NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion wasGeneratedBy ECO_0000203 NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.